Increased risk of mycobacterial infections associated with anti-rheumatic medications.
about
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung DiseaseDoes tuberculosis threaten our ageing populations?'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infectionThe risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of AsthmaPulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012.Risk Factors and Outcomes of Nontuberculous Mycobacterial Disease among Rheumatoid Arthritis Patients: A Case-Control study in a TB Endemic AreaRisk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.Emerging biologics in inflammatory bowel disease.Prosthetic Joint Infection due to Mycobacterium avium-intracellulare in a Patient with Rheumatoid Arthritis: A Case Report and Review of the LiteratureNontuberculous mycobacteria in Denmark, incidence and clinical importance during the last quarter-century.Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.[Nontuberculous mycobacterial infections].Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.Profiling non-tuberculous mycobacteria in an Asian setting: characteristics and clinical outcomes of hospitalized patients in Singapore.Hospital-based antibiotic use in patients with complex
P2860
Q26748674-6D284466-C96F-4627-BF41-4E0798150557Q26766255-9EAEEA11-69A0-4C27-ADC9-02DFBD3F163BQ28070339-57121D6F-839D-44A2-A52D-78909F2E81F4Q33751643-92F23D5D-C9E9-45C6-A6F4-5C2FD8D54A02Q35716467-6C91F6F1-5557-48A2-88C7-3A75F8254FBBQ36011261-3F5EF73E-0AD0-45C2-8B66-C6B00C95580AQ37086326-9D935CEC-691D-4187-9B2E-E8BF2089CFB3Q37576833-61709048-D078-426B-8981-307B2BE53175Q39004625-273C720E-FC3E-47B5-8901-7C1B8647E326Q39172142-07C1E5EB-0C67-4942-ACE9-58C0AFDC8895Q40116290-943AB211-E080-476B-BE0C-72B8F5CC1C40Q47756838-34CD7E99-C331-42EE-B36A-004634C99D93Q50086071-D6E26CC1-F1D3-42BD-8EBA-01D5C405B79FQ52675348-517580B3-291C-4107-B9CC-C1E28E0069ACQ55268830-D00EF7D6-2A90-42FA-BAC3-EE9149B334FDQ58616174-6A00DD82-3BF1-421F-88C0-11C58C6B1C17
P2860
Increased risk of mycobacterial infections associated with anti-rheumatic medications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Increased risk of mycobacterial infections associated with anti-rheumatic medications.
@en
type
label
Increased risk of mycobacterial infections associated with anti-rheumatic medications.
@en
prefLabel
Increased risk of mycobacterial infections associated with anti-rheumatic medications.
@en
P2093
P2860
P1433
P1476
Increased risk of mycobacterial infections associated with anti-rheumatic medications.
@en
P2093
Claire Bombardier
Frances B Jamieson
J Michael Paterson
Jeffrey C Kwong
Michael A Campitelli
Sarah K Brode
Theodore K Marras
P2860
P304
P356
10.1136/THORAXJNL-2014-206470
P407
P577
2015-04-24T00:00:00Z